Fluoxetine Unichem

Quick links to important sections

Fluoxetine Unichem

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluoxetine Unichem

Understanding Fluoxetine Unichem

Fluoxetine Unichem is a pharmaceutical formulation containing fluoxetine hydrochloride, a medication belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used in the management of various mental health conditions, focusing on stabilizing mood and emotional response.

Therapeutic Class and Mechanism

As an SSRI, fluoxetine works by increasing the extracellular level of the neurotransmitter serotonin. It achieves this by limiting its reabsorption (reuptake) into the presynaptic cell. By maintaining higher levels of serotonin in the synaptic cleft, the medication helps improve the transmission of signals between nerve cells, which plays a significant role in regulating mood, sleep, and appetite.

Primary Applications

Fluoxetine Unichem is commonly utilized in the treatment of several psychological and behavioral health conditions:

  • Major Depressive Disorder: It is used to help alleviate persistent feelings of sadness and loss of interest.
  • Obsessive-Compulsive Disorder (OCD): It assists in managing repetitive thoughts and behaviors.
  • Panic Disorder: It is used to reduce the frequency and intensity of panic attacks.
  • Bulimia Nervosa: It is utilized as part of a comprehensive approach to reduce binge-eating and purging behaviors.
  • Premenstrual Dysphoric Disorder (PMDD): It may be used to stabilize the severe physical and emotional symptoms associated with the menstrual cycle.

Physical Characteristics

Fluoxetine Unichem is typically produced in oral capsule or tablet forms. The specific appearance, including color and shape, may vary depending on the strength of the dose provided. As a generic version of fluoxetine, it contains the same active ingredient as the original brand-name formulations, designed to meet the same standards for quality and performance.

What side effects are possible with Fluoxetine Unichem?

Possible Side Effects and Safety Information

Like all medicines, Fluoxetine Unichem can cause side effects, although not everybody gets them. Side effects are often mild and may lessen as your body adjusts to the medication. It is important to continue treatment unless otherwise advised by your doctor.

Common Side Effects

These side effects are frequently reported and often occur during the first few weeks of treatment. They may include:

  • Gastrointestinal issues: Nausea, diarrhea, dry mouth, or loss of appetite.
  • Nervous system: Headache, insomnia (trouble sleeping), nervousness, anxiety, tremor, or feeling weak/tired (asthenia).
  • Sexual dysfunction: Decreased libido, difficulty reaching orgasm, or ejaculatory delay/failure.
  • Other: Sweating, abnormal dreams, or yawning.

Serious Side Effects

Seek immediate medical attention if you experience any of the following serious side effects, which can indicate a severe reaction or condition:

  • Serotonin Syndrome: A combination of symptoms such as agitation, hallucinations, confusion, fast heart rate, fever, excessive sweating, shivering, twitching, and severe muscle stiffness. This is a rare but potentially life-threatening reaction, often linked to use with other serotonergic drugs.
  • Suicidal Thoughts or Behavior: Especially at the beginning of treatment or after a dose change, in children, adolescents, and young adults (up to age 25).
  • Allergic Reactions: Signs may include rash, hives, swelling of the face, lips, or tongue, or difficulty breathing.
  • Abnormal Bleeding/Bruising: Increased risk of bleeding, especially when taken with medications like NSAIDs or anticoagulants. Signs include unexplained bruising or black/bloody stools.
  • Activation of Mania/Hypomania: Symptoms such as increased energy, reckless behavior, racing thoughts, or extreme happiness.

Safety Considerations

  • Interactions: Inform your doctor about all medications you take, especially MAO Inhibitors (MAOIs), pimozide, or thioridazine, as Fluoxetine Unichem is contraindicated with these due to the risk of serious side effects.
  • Withdrawal: While fluoxetine has a long half-life, abrupt discontinuation should be avoided to minimize symptoms like dizziness, nausea, and headache. Your doctor will advise on a gradual tapering schedule.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Fluoxetine based on documented clinical manifestations and required emergency actions. Overdose may present across a spectrum of severity, affecting the Central Nervous System (CNS), cardiovascular, and autonomic systems.

Documented Overdose Manifestations

System Symptoms and Signs (Regulatory-Listed)
CNS Drowsiness, tremor, agitation, confusion, seizures.
Cardiovascular Tachycardia, QT interval prolongation, ventricular arrhythmia.
Gastrointestinal Nausea, vomiting, diarrhea.

Serious outcomes documented in regulatory texts include severe reactions like Serotonin Syndrome (Serotonin Toxicity), Rhabdomyolysis, coma, and Cardiac Arrest. These risks are notably increased by co-ingestion with other serotonergic agents or alcohol. The prolonged half-life of Fluoxetine and its active metabolite necessitates extended monitoring in overdose cases.

Required Emergency Action

Regulatory authorities explicitly mandate that for any suspected overdose, immediate medical attention must be sought (contacting emergency services). Since no specific antidote is known, management is strictly symptomatic and supportive. Hospital monitoring, including ECG monitoring, is generally required due to the documented potential for serious cardiac abnormalities and the risk of delayed symptom onset.

Therapeutic Uses of Fluoxetine Unichem

What Fluoxetine Unichem Treats: Main Uses and Benefits

Fluoxetine Unichem is relevant within therapeutic areas where additional symptomatic support is needed for mood dysregulation and anxiety-driven behaviors. The medication is commonly applied in addressing conditions where symptoms may intensify temporarily and interfere with daily comfort. Its applications include addressing conditions such as Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and Bulimia Nervosa. It is also relevant for use in pediatric patients with MDD or OCD.

The support provided contributes to symptomatic relief, helping to ease the overall symptom load during difficult episodes. It supports maintaining a sense of stability when symptoms create noticeable functional strain, such as sudden panic attacks or intrusive obsessions. It is considered relevant for use in complex presentations, including Treatment Resistant Depression (as part of specific co-therapy).


Quick Fact: Symptom Relief Focus

Symptom Cluster Benefit Focus
Pervasive low mood and anhedonia Supports emotional balance and helps ease symptomatic sadness.
Intrusive thoughts and rituals Helps ease the symptomatic burden of obsessions and compulsions.
Binge-eating and purging May assist with managing specific behaviors.
Acute fear and cyclical irritability Provides supportive relief when symptoms create noticeable physiological strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Fluoxetine Unichem?

The eligibility for Fluoxetine Unichem is strictly defined by regulatory guidelines, establishing absolute prohibitions and conditional requirements based on patient population and health status.


Ineligible Populations (Contraindications)

Category Restriction Status
Hypersensitivity Known allergy to Fluoxetine or its excipients. Contraindicated
Drug Interactions Concurrent use with MAOIs, Pimozide, or Thioridazine. Prohibited
Unstable Health Patients with unstable seizure disorders/epilepsy. Ineligible

Restricted or Conditional Use

Age Restrictions: The medicine is generally not recommended for children under 8 years old. Use in adolescents (8 years and older) for Major Depressive Episode is conditional; it must be combined with concurrent psychological therapy and is often reserved for those unresponsive to therapy alone.

Organ Function: Patients with severe hepatic impairment or severe renal impairment have limited eligibility, often requiring a lower dose or less frequent administration, as the drug's clearance is altered.

Pregnancy/Lactation: Breastfeeding is not recommended as Fluoxetine is excreted in milk. During pregnancy, use is restricted and considered only if the potential benefit outweighs the potential risks to the fetus.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Fluoxetine Unichem is defined by two principal types of officially documented regulatory interactions.

Prohibited Combinations and Timing Rules

Regulatory documents strictly prohibit co-administration with Monoamine Oxidase Inhibitors (MAOIs), Pimozide, Thioridazine, Linezolid, and Intravenous Methylene Blue due to severe risks.

Interaction Type Mandatory Requirement
Fluoxetine to MAOI/Thioridazine A mandatory five-week washout period is required after discontinuation.
MAOI to Fluoxetine A minimum fourteen-day washout period is required after discontinuation.

Metabolic and Pharmacodynamic Interactions

Fluoxetine is classified as a potent inhibitor of the enzyme CYP2D6. This pharmacokinetic interaction may result in increased plasma concentrations of co-administered medicines metabolized by this enzyme, including certain antipsychotics and tricyclic antidepressants.

A major pharmacodynamic interaction is the increased risk of Serotonin Syndrome when combined with other serotonergic agents, such as Triptans, Lithium, or the supplement St. John's Wort. Co-administration with agents that interfere with hemostasis, such as NSAIDs or Warfarin, is documented to potentiate the risk of bleeding. While food does not significantly impact systemic availability, regulatory guidance recommends avoidance of alcohol due to potential additive impairment. Clearance is officially noted as delayed in individuals with hepatic impairment, leading to prolonged exposure.

Mechanism of Action

Fluoxetine functions primarily as a selective serotonin reuptake inhibitor (SSRI) within the central nervous system. Its molecular action involves binding with high affinity to the serotonin transporter (SERT) protein located on the presynaptic neuronal membrane. This binding event sterically occludes the active site, competitively inhibiting the transporter's normal function of moving serotonin (5-HT) from the synaptic cleft back into the presynaptic neuron's cytoplasm. The resultant inhibition of 5-HT reuptake leads to an elevated and sustained concentration of serotonin within the synaptic space. This increased availability of the neurotransmitter facilitates greater and prolonged activation of postsynaptic 5-HT receptors. The subsequent and continual enhancement of serotonergic neurotransmission modulates complex neurochemical cascades, influencing key neuronal circuits and cellular processes within the brain.

Dosage and Administration Information

Official Administration Guidelines

Fluoxetine Unichem is an orally administered medication, available as immediate-release capsules or tablets. The general principle for use involves a gradual dosage adjustment over time. The medication may be taken with or without food as its absorption is not affected by mealtimes.

Dosing and Schedule Principles

Category Administration Instructions
Route of Administration Oral administration only (capsule, tablet, or oral solution).
Standard Daily Dosing Treatment for most adult indications starts at 20 mg daily. For Bulimia Nervosa, the recommended dose is 60 mg daily. The maximum studied daily dose ranges from 60 mg to 80 mg.
Frequency and Timing Typically administered once daily in the morning. Doses above 20 mg per day may be given in divided doses (morning and noon). The 90 mg delayed-release form is used once weekly.
Treatment Duration The dose may be increased gradually after several weeks if clinical response is insufficient. For Major Depressive Disorder, treatment should be continued for a sufficient period, often at least six months after symptom recovery.

Population-Specific Instructions

Certain patient populations require specific dosage modifications. For older adults, caution is advised when increasing the dose, and the total daily dose should generally not exceed 40 mg. Patients with hepatic impairment should receive a lower or less frequent dose (e.g., 20 mg every second day) due to decreased clearance. For pediatric patients (MDD aged 8 years and older; OCD aged 7 years and older), treatment begins with a lower daily starting dose, such as 10 mg, and is subject to specialist supervision.

Recent Clinical Evidence

Research evidence / Overview of studies for Fluoxetine Unichem

Evidence for Use in Major Depressive Disorder (MDD)

Research primarily utilized Randomized Controlled Trials (RCTs) and meta-analyses to study the medicine for Major Depressive Disorder in adults and in children and adolescents over age eight. Studies focused on outcomes related to episodic changes in core depressive symptoms. Short-term trials spanning eight to twelve weeks reported patterns where symptom scores differed between the medicine and placebo groups. Research also examined the durability of the measured change in trials designed to monitor for the return of depressive symptoms. Long-term effects are not fully established beyond six to eight months, and findings were mixed regarding consistency in pediatric data.

Evidence for Use in Obsessive-Compulsive Disorder (OCD)

Research explored the medicine's role in OCD using RCTs and systematic reviews. Studies monitored outcomes reflecting daily functioning or activity level related to the severity of obsessive thoughts and compulsive actions in both adults and young people aged seven and older. Trials lasting up to sixteen weeks reported measured changes in symptom scores. There is limited information for long-term outcomes regarding the durability of symptom change, and comparative evidence is lacking against established non-pharmacological therapies.

Evidence for Use in Bulimia Nervosa (BN)

The evidence base consists mainly of RCTs in adults, monitoring the frequency of specific behaviors such as binge eating and purging. Acute studies reported measured changes that were often dependent on the use of a defined dose regimen. A significant portion of the core evidence appears to be older, and limited information for long-term outcomes exists regarding the stability of measured behavioral changes beyond one year.

Long-Term Studies, Special Populations, and Uncertainty

Research has explored the medicine's role beyond short-term treatment by focusing on patterns related to preventing the return of symptoms. Studies outline how research has been studied for its use in special groups, specifically children and adolescents. The final research synthesis highlights areas where data for certain groups remain insufficient, emphasizing that results apply only to the populations studied, and key limitations include where follow-up durations were limited.

Frequently Asked Questions (FAQ)

Common questions about Fluoxetine Unichem (FAQ)

Q: How quickly does Fluoxetine Unichem typically start to work?

The onset of symptom improvement with Fluoxetine Unichem is typically not immediate. Official product information indicates that physicians generally review the dosage after several weeks if the initial response is insufficient. Significant changes in response may not be fully observed for several weeks after starting treatment.

Q: How long do people usually stay on Fluoxetine Unichem?

The required duration of use depends on the condition being addressed. According to regulatory guidelines for Major Depressive Episodes, treatment is generally continued for a sufficient period, often for at least six months after symptoms have improved. Official guidelines emphasize that the need for ongoing treatment is subject to periodic re-evaluation.

Q: What are some common side effects that people experience on Fluoxetine Unichem?

Regulatory documents list common side effects often reported by patients, which frequently occur during the first few weeks of treatment. These may include nervous system effects such as headache, insomnia, or nervousness, and gastrointestinal effects like nausea or diarrhea. Other reported common effects include decreased sex drive or difficulty with orgasm/ejaculation.

Q: What are the typical withdrawal symptoms when stopping Fluoxetine Unichem (as described in official sources)?

Official information advises against suddenly stopping Fluoxetine Unichem to minimize potential discontinuation symptoms. Reported symptoms when the medicine is stopped include dizziness, headache, nausea, sensory disturbances, and sleep disturbances like abnormal dreams. Official guidance emphasizes that treatment cessation is typically managed gradually under professional supervision.

Q: Can I take Fluoxetine Unichem if I have liver problems?

Eligibility for Fluoxetine Unichem is restricted for patients with severe hepatic impairment (liver problems). Because the liver processes and eliminates the drug slowly in these cases, official guidelines indicate that a lower or less frequent dose may be necessary. Any necessary dosage adjustments are determined by a healthcare provider.

Q: Is Fluoxetine Unichem safe to use during pregnancy (as described in official sources)?

Regulatory documents indicate that the use of Fluoxetine Unichem during pregnancy is restricted. It is considered only if the potential benefit to the mother is determined to justify the potential risk to the fetus. There is also an increased risk of certain effects on the newborn if the medication is used late in the pregnancy.

Q: What is the scientific evidence regarding Fluoxetine Unichem and sexual side effects?

Sexual dysfunction is documented in regulatory sources as a common adverse drug reaction. This may include decreased libido and difficulties with orgasm or ejaculation. While sexual dysfunction is a commonly listed side effect, detailed themes of clinical studies are generally not present in patient information leaflets.

Q: Can Fluoxetine Unichem cause weight gain or weight loss?

Official regulatory documents list both weight loss and weight gain as reported adverse drug reactions. In short-term studies, some patients experienced slight weight loss. However, long-term clinical data shows that changes can include modest increases in weight over time compared to placebo.

Q: Is Fluoxetine Unichem a controlled substance?

Fluoxetine is not classified as a controlled substance under the U.S. Controlled Substances Act or equivalent international drug scheduling/control classifications. The drug is not typically associated with the addictive properties or potential for abuse seen with substances placed under control classifications.

Q: What is the difference between Fluoxetine Unichem and Prozac?

Fluoxetine Unichem is a generic formulation containing the active ingredient Fluoxetine. Prozac is a well-known brand name for the exact same active ingredient. Both products contain Fluoxetine and share the same established pharmacological profile and method of action.

Q: Is it normal to feel a bit worse when first starting Fluoxetine Unichem?

Official patient information notes that some individuals taking antidepressants may initially feel worse before experiencing improvement. This initial experience can occur alongside the risk of suicidal thoughts and behaviors noted in younger adults, especially at the start of treatment or following dosage changes.

Q: How long does Fluoxetine Unichem stay in the body after the last dose?

Fluoxetine and its active substance, norfluoxetine, have long elimination half-lives, meaning they take an extended period to leave the body. The drug may persist in the body for up to five or six weeks after treatment has been fully stopped. The prolonged presence of the medication is a key factor in required washout periods before starting certain other treatments.

Q: Does Fluoxetine Unichem show up on drug tests?

Fluoxetine itself is not a substance of abuse; however, it may interfere with the results of certain laboratory tests. Official guidance notes that patients are typically advised to inform laboratory personnel about the use of Fluoxetine Unichem before having certain lab work performed.

Q: Does taking Fluoxetine Unichem make driving or operating machinery difficult?

Regulatory information advises caution regarding driving or operating machinery. The medication may cause effects like drowsiness or difficulties with coordination that could impair the ability to perform tasks requiring alertness. Patients are cautioned to exercise care until they are certain the medication does not adversely affect their ability to drive or operate machinery.

Q: Can Fluoxetine Unichem cause stomach issues?

Yes, gastrointestinal issues are frequently reported side effects. Regulatory documents list common effects such as nausea, diarrhea, vomiting, dry mouth, and loss of appetite. Reported patterns suggest these effects may become less frequent as the body adjusts to the medication.

Q: Is it possible to develop a dependency on Fluoxetine Unichem?

Fluoxetine Unichem is generally not associated with the addictive properties seen in controlled substances. However, because of the risk of discontinuation symptoms like dizziness and headache when stopping, official guidelines indicate that when stopping treatment, a gradual reduction is typically required to avoid discontinuation symptoms.

Q: Does Fluoxetine Unichem affect fertility?

Official information derived from animal studies suggests that Fluoxetine may have an effect on sperm quality, which could potentially impact male fertility. Official drug information often notes that the potential effect on human fertility requires caution due to the limited nature of the available human data.

Q: How is Fluoxetine Unichem different from other SSRIs?

Like all SSRIs, Fluoxetine Unichem works by increasing serotonin levels in the brain. Its primary difference from most other medications in this class is its significantly longer half-life, meaning it remains active in the body for a much longer period. This influences factors such as the required washout time before starting other treatments.

Q: Is Fluoxetine Unichem approved for chronic pain conditions?

Fluoxetine is officially indicated and approved only for the treatment of Major Depressive Disorder, Obsessive-Compulsive Disorder, Bulimia Nervosa, and Premenstrual Dysphoric Disorder. It is not listed or approved by regulatory bodies for the primary treatment of chronic pain conditions.

Q: Can Fluoxetine Unichem cause changes in appetite?

Yes, changes in appetite are recognized as a reported side effect of Fluoxetine Unichem. Regulatory documents specifically list loss of appetite (anorexia) as a common side effect experienced by some patients.

Q: Does Fluoxetine Unichem affect sleep?

Yes, official safety information lists several sleep-related effects. Both insomnia (difficulty sleeping) and abnormal dreams are commonly reported. Less frequently, drowsiness may also occur. These effects are classified as nervous system disorders.

Q: What is the long-term evidence for using Fluoxetine Unichem?

Clinical research has examined Fluoxetine Unichem's role in preventing the return of symptoms following initial improvement. However, regulatory summaries indicate that long-term effects beyond periods like six to eight months are not fully established for all indications, and follow-up data for certain groups may remain limited.

Q: Does Fluoxetine Unichem have a 'black box' warning, and what does it mean?

Yes, Fluoxetine carries a Boxed Warning—the FDA's most stringent caution. This warning concerns the increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24) when taking antidepressants. This risk is highest at the beginning of treatment or following a change in dosage.

How should Fluoxetine Unichem be stored and disposed of?

Official Storage and Disposal Requirements

The stability and safety of Fluoxetine are maintained by adhering to specific regulatory handling and storage instructions.

Storage Condition Requirement Child Safety/Disposal
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Keep medicine out of the sight and reach of children.
Container/Protection Keep in the original container, tightly closed, and protect from moisture. Do not dispose of via wastewater or household waste.
Expiry/Handling Do not use the medicine after the expiry date. Return unused or expired product to a pharmacist for proper disposal.

Fluoxetine must be stored in a dry place away from heat to ensure chemical stability. Disposal must follow pharmaceutical waste protocols to prevent environmental contamination, as discarding the product in household waste or wastewater is explicitly prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluoxetine Unichem found in:

A-Z Index: